Bottom line
How much do FACDX and GGHCX overlap?
47% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 35.2% of FACDX's assets and 46.5% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FACDX and GGHCX have in common
| Holding | % of FACDX | % of GGHCX | Overlap |
|---|---|---|---|
| ELI LILLY and CO | 7.66% | 10.59% | 7.66% |
| Thermo Fisher Scientific Inc | 6.31% | 1.55% | 1.55% |
| Unitedhealth Group Inc | 4.17% | 6.17% | 4.17% |
| JOHNSON and JOHNSON | 3.78% | 6.76% | 3.78% |
| Abbvie Inc | 3.62% | 4.03% | 3.62% |
| Argenx Se | 2.09% | 3.24% | 2.09% |
| MERCK and CO INC | 2.09% | 4.59% | 2.09% |
| Guardant Health Inc | 1.48% | 2.04% | 1.48% |
| Waters Corp | 1.43% | 1.41% | 1.41% |
| Cvs Health Corp | 1.29% | 2.52% | 1.29% |
| Gilead Sciences Inc | 1.25% | 3.63% | 1.25% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FACDX
- Danaher Corp — 6.75%
- Fidelity Revere Street Trust — 2.54%
- West Pharmaceutical Svcs Inc — 2.06%
- Ascendis Pharma A/s — 1.95%
- Alnylam Pharmaceuticals Inc — 1.78%
- Agilent Technologies Inc — 1.75%
- Viatris Inc — 1.67%
- Natera Inc — 1.65%
- 10x Genomics Inc — 1.45%
- Revolution Medicines Inc — 1.44%
- Oruka Therapeutics Inc — 1.32%
- Ucb Sa — 1.32%
- Boston Scientific Corp — 1.23%
- Repligen Corp — 1.22%
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Cardinal Health, Inc. — 2.10%
- Vertex Pharmaceuticals Inc. — 2.01%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Asset mix
| Asset type | FACDX | GGHCX |
|---|---|---|
| Stocks | 97.7% | 97.5% |
| Cash & short-term funds | 2.8% | 8.8% |
| Preferred stock | 2.1% | — |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | FACDX | GGHCX |
|---|---|---|
| US | 88.0% | 93.5% |
| NL | 2.9% | 3.4% |
| GB | 2.6% | 3.1% |
| CH | 0.5% | 2.7% |
| DK | 2.0% | 1.1% |
| BE | 1.3% | 1.2% |
| KY | 1.3% | — |
| BM | 1.0% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FACDX and GGHCX overlap?
What stocks do FACDX and GGHCX have in common?
Should I own both FACDX and GGHCX?
Which holds more stocks, FACDX or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.